Lv3
400 积分 2022-12-13 加入
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
4个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
4个月前
已完结
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
1年前
已完结
Steroids use and survival in patients with glioblastoma multiforme: a pooled analysis
1年前
已关闭
皖公网安备34019202002308
